新型的黄-复合物作为血膜 ATPase 的抑制剂

相关实验视频

Updated: Sep 12, 2025

12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

11.1K

Mallku Q Ontiveros¹, Mariel Marder¹, Rolando C Rossi¹

¹Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Biológica, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Instituto de Química y Fisicoquímica Biológicas Prof. Alejandro C. Paladini (IQUIFIB), Buenos Aires, Argentina.

Biochimica et biophysica acta. Biomembranes

|August 5, 2025

概括

素是一种黄类化合物,通过形成复合物来抑制人类的PMCA4,提供一种控制水平和治疗相关疾病的新方法.

科学领域:

生物化学生物化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

血膜 ATPases (PMCA) 调节细胞内 (Ca2+),这对细胞功能至关重要.
PMCA的失调与神经,心血管,瘤和代谢疾病有关.
调节PMCA活动的特定工具很少,阻碍了治疗的发展.

研究的目的:

研究奎尔丁在人类PMCA4异型 (hPMCA4) 上的抑制机制.
阐明素- (Mg2+) 复合体在PMCA抑制中的作用.
探索用于设计新型PMCA抑制剂的结构-活性关系.

主要方法:

紫外线可见光谱学
测定ATPase活性测定
在不同的pH值下进行功能和酸化研究.
结构-活动关系分析分析.

主要成果:

Quercetin 通过一个Quercetin-Mg2+复合体 (Ki = 49.7 ± 1.5 nM) 高亲和度抑制hPMCA4.
确定了两个抑制机制:高亲和力 (quercetin-Mg²⁺复合体) 和低亲和力 (自由).
奎尔素在3',4'和3位的基基组对于抑制性强度和复合物形成至关重要.

结论:

黄-Mg2+复合体代表了调节PMCA活性的一种新机制.
这些复合体可以作为选择性的分子工具来调节Ca2+运输.
这些发现为设计PMCA抑制剂和开发治疗信号相关疾病的方法提供了洞察力.

关键词:

黄类化合物黄类化合物抑制抑制的抑制作用复合物复合物复合物这就是PMCA.血膜中的 ATPase 是一种 ATPase.

相关概念视频

01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

772

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...

772

01:16

Calmodulin-dependent Signaling

5.3K

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

5.3K

01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

683

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

683

01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

992

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

992

01:30

The Electron Transport Chain

17.3K

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

17.3K

01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

1.2K

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...